4,7-Dibromo-5,6-bis(dodecyloxy)benzo[c][1,2,5]thiadiazole

Catalog No. :
ACUXRC376
CAS No. :
1313876-00-4
Molecular Formula :
C30H50Br2N2O2S
Molecular Weight :
662.62

IUPAC Name:4,7-dibromo-5,6-bis(dodecyloxy)benzo[c][1,2,5]thiadiazole

4,7-Dibromo-5,6-bis(dodecyloxy)benzo[c][1,2,5]thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$107.00Login to see priceIn stockInquiry
5g95%$386.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,7-Dibromo-5,6-bis(dodecyloxy)benzo[c][1,2,5]thiadiazole
IUPAC Name4,7-dibromo-5,6-bis(dodecyloxy)benzo[c][1,2,5]thiadiazole
Molecular FormulaC30H50Br2N2O2S
Molecular Weight662.62
SMILESCCCCCCCCCCCCOC1=C(Br)C2=NSN=C2C(Br)=C1OCCCCCCCCCCCC
InChI KeyDVDXEQCMUYXONV-UHFFFAOYSA-N
SynonymC30H50Br2N2O2S | 1313876-00-4 | AKOS022174854 | MFCD27923049 | D4622 | 2,1,3-Benzothiadiazole, 4,7-dibromo-5,6-bis(dodecyloxy)- | AMY27169 | F20652 | 4,7-dibromo-5,6-didodecoxy-2,1,3-benzothiadiazole | DS-7537 | 4,7-Dibromo-5,6-bis(dodecyloxy)benzo[c][1,2
CAS No.1313876-00-4
PubChem CID71143603

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUXRC376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUXRC376 route product structure diagram
    ACUXRC3761313876-00-4 In Stock
Inquiry

2. ACUXRC376 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUXRC376 route product structure diagram
    ACUXRC3761313876-00-4 In Stock
Inquiry

Comments (0)